Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Immunome ( (IMNM) ) just unveiled an announcement.
On January 21, 2025, Immunome, Inc.’s CFO, Max Rosett, accepted a relocation package to move to Bothell, Washington. The package includes a $100,000 cash bonus contingent on his move by January 21, 2026, and employment retention, plus a $300,000 housing bonus tied to purchasing a home and staying with the company for three years, with specific repayment obligations.
More about Immunome
YTD Price Performance: -3.42%
Average Trading Volume: 820,845
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $634.8M
See more insights into IMNM stock on TipRanks’ Stock Analysis page.
